சுகாதாரம் இல் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுகாதாரம் இல் இந்தியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுகாதாரம் இல் இந்தியா Today - Breaking & Trending Today

Exports jump to $32.21 bn in May, up 67%; trade deficit at $6.32 billion

Read more about Exports jump to $32.21 bn in May, up 67%; trade deficit at $6.32 billion on Business Standard. India s exports grew by 67.39% to $32.21 billion in May driven by healthy growth in sectors such as engineering, pharmaceuticals, petroleum products and chemicals ....

Healthcare In India , Pharmaceutical Industry In India , Petroleum Products , Oil Imports , சுகாதாரம் இல் இந்தியா ,

Sensex climbs 111 pts, Nifty ends below 15,200; SBI jumps 2.7%, L&T up 1.7%


Equity indices ended with small gains on Monday, supported by firmness in banks stocks. The Nifty closed below the 15,200 mark after trading above that level for most part of the session. The moderation in daily new COVID-19 cases in India improved risk sentiments. Barring FMCG and metal, all the sectoral indices on the NSE ended in the green.
The barometer index, the S&P BSE Sensex, rose 111.42 points or 0.22% at 50,651.90. The Nifty 50 index gained 22.40 points or 0.15% at 15,197.70.
State Bank of India (up 2.73%), Larsen & Toubro (up 1.74%) and Axis Bank (up 1.40%) supported the indices.
The broader market outperformed the benchmark indices. The BSE Mid-Cap index added 0.86% and the BSE Small-Cap index rose 0.70%. ....

United States , North Carolina , Andhra Pradesh , Jagran Prakashan , Trastuzumab Emtansine , Lal Pathlabs , Arvind Kejriwal , Natco Pharma , Saurabh Mukherjea , Larsen Toubro , Dow Jones , Bharat Parenterals , Axis Bank , Ministry Of Health , United States Food Drug Administration , Multi Exchange Commodity Of India , Tv Today Network , Db Corp , Container Corporation Of India , Harrow International , Power Grid Corporation Of India , Global Parts Centre , Drug Administration , Glenmark Pharmaceuticals , Federal Reserve , Central Drugs Standard Control Organisation ,

GSK Pharma skids after Q4 PAT tumbles 90% YoY to Rs 14 cr


Glaxosmithkline Pharmaceuticals fell 1.75% to Rs 1,489.15 after the company s consolidated net profit tanked 89.6% to Rs 14.33 crore on 4.9% increase in net sales to Rs 813.75 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax (PBT) dropped 64.3% to Rs 63.01 crore in Q4 FY21 from Rs 176.55 crore in Q4 FY20. The Q4 result was declared post market hours yesterday, 18 May 2021.
On a standalone basis, revenue for the quarter came in at Rs 807 crore, recording an underlying growth of 6%. Total income came in at Rs 837 crore as compared to Rs 791 crore for the quarter ended 31st March 2020. PBT (before exceptional) for the quarter at Rs 180 crore, recorded a growth of 9%. ....

Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals , Fluarix Tetra , Direct Relief , Capital Market , Healthcare In India , Pharmaceutical Industry In India , Harmaceuticals Nec , Fluarix Tetra , Gsk Pharma , Anti Infectives , Glaxosmithkline Plc , Managing Director , Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals , ஸ்ரீதர் வெங்கடேஷ் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் , நேரடி துயர் நீக்கம் , மூலதனம் சந்தை , சுகாதாரம் இல் இந்தியா ,